sustained EB-1A

Cardiac Physiologist

Cardiac Physiology · India · 2024-08-16

Decision Date
2024-08-16
This case is from a USCIS Administrative Appeals Office (AAO) appeal decision. Appeal cases represent a subset of petitions and may not reflect typical outcomes.

Framework Evaluation

3 of 3 criteria met
Participation as a judge of the work of others (Met)

The Director found that the Petitioner successfully submitted evidence of his participation as a judge of others' work in his field.

Original scientific, scholarly, artistic, athletic, or business-related contributions of major significance in the field (Met)

The Director found that the Petitioner successfully submitted evidence of his original contributions of major significance in his field.

Authorship of scholarly articles in the field, in professional or major trade publications or other major media (Met)

The Director found that the Petitioner successfully submitted evidence of his authorship of scholarly articles in the field.

Why This Petition Was Approved

The AAO sustained the appeal, finding the Director overlooked crucial evidence. The Petitioner's seven research papers, published since 2019, garnered over 900 citations from 55 countries, placing him in the top 1% of authors in clinical medicine. His research on hydroxychloroquine and azithromycin's cardiac risks led to an FDA warning, demonstrating global importance and impact on public health. Additionally, his work on left ventricular assist devices and reducing CIED-implant patient discharge times significantly advanced clinical guidelines, as endorsed by independent medical professors.

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Media Coverage
Reference Letters Independent
Original Contributions
Judging Experience
Scholarly Articles
Evidence Submitted
  • Seven research papers co-authored since 2019 in peer-reviewed journals
  • Over 900 citations from doctors and scientists in 55 countries
  • Research on hydroxychloroquine and azithromycin's cardiac risks, leading to FDA warning and media coverage
  • Research on left ventricular assist devices (LVADs) improving pulmonary artery pressure
  • First-authored research leading to reduced discharge times for CIED-implant patients (from 24 to 6 hours)
  • Citation rate placing him in the top 1% of authors in the clinical medicine category

Similar Cases

Cardiologist

Healthcare · India

WeGreened EB-1A rfe approved
Arizona 118 days 2025-05-01
The approval was based on 81 peer-reviewed articles and 49 conference abstracts with over 1,110 citations, placing the petitioner in the top 1% of his field. He completed over 100 peer reviews for top journals like JACC and served on editorial boards. His innovative techniques, such as micropuncture access, have become standard references in medical literature.

Clinical Researcher

Healthcare · India

WeGreened EB-1A approved
New York 14 days 2025-03-13
The petition was approved based on meeting multiple EB-1A criteria, including 81 peer-reviewed journal articles and 62 conference abstracts. The applicant demonstrated significant impact through over 800 citations and participation as a judge of others' work with 52 peer reviews. The evidence established the petitioner as an alien of extraordinary ability whose work aligns with public health priorities.

Research Scientist

Healthcare · India

WeGreened EB-1A approved
Ohio 14 days 2025-01-10
The petition was approved based on a high citation impact (over 1,100 citations) and a prolific publication record (54 peer-reviewed articles). The petitioner satisfied the EB-1A criteria through his extensive peer review work (17 reviews), editorial board memberships for three major journals, and original contributions that rank in the top 10% of most-cited papers in Clinical Medicine.

Postdoctoral Researcher

Healthcare · Iran

WeGreened EB-1A approved
Maryland 126 days 2025-10-29
The petition was approved based on a record of 7 peer-reviewed journal articles, 2 first-authored abstracts, and 2 preprints that garnered 309 citations from independent scholars. The petitioner also demonstrated sustained acclaim through the completion of at least 19 peer reviews for high-level academic journals. These metrics satisfied the EB-1A criteria for scholarly articles, original contributions, and judging the work of others.

Frequently Asked Questions

A sustained EB-1A (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

Case data sourced from publicly available petition decisions and case studies. Decision date: 2024-08-16.

Browse all cases

At a Glance

Outcome sustained
Criteria Met 3 / 3
Evidence Types 7

EB-1A Case Data

Scraped Case Data

Total Cases 919
Success Rate 53.0%
Sustained 487
Dismissed 315

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist